Encompass Health Corporation Operating Income
Encompass Health Corporation (EHC) reported Operating Income of $151.90 million for the 3-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-02-27
- Encompass Health Corporation operating income (loss) for the quarter ending 2022-12-31 was $151.90M, a 18.30% increase year-over-year.
- Encompass Health Corporation operating income (loss) for the quarter ending 2022-09-30 was $127.50M, a 9.83% decline year-over-year.
- Encompass Health Corporation operating income (loss) for the quarter ending 2022-06-30 was $128.60M, a 12.40% decline year-over-year.
- Encompass Health Corporation operating income (loss) for the quarter ending 2022-03-31 was $131.50M, a 8.04% decline year-over-year.
- Encompass Health Corporation operating income (loss) for fiscal 2022 was $539.50M, a 3.59% decline from fiscal 2021.
- Encompass Health Corporation operating income (loss) for fiscal 2021 was $559.60M, a 0.76% decline from fiscal 2020.
- Encompass Health Corporation operating income (loss) for fiscal 2020 was $563.90M, a 7.87% decline from fiscal 2019.
- Encompass Health Corporation operating income (loss) for fiscal 2019 was $612.10M, a 10.25% increase from fiscal 2018.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $151.90M 10-K · filed 2023-02-27 | $279.40M derived: sum of 2 quarters · filed 2023-02-27 | $408.00M derived: sum of 3 quarters · filed 2023-02-27 | $539.50M 10-K · filed 2023-02-27 |
| 2022-09-30 | $127.50M 10-K · filed 2023-02-27 | $256.10M derived: sum of 2 quarters · filed 2023-02-27 | $387.60M derived: sum of 3 quarters · filed 2023-02-27 | $516.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2022-06-30 | $128.60M 10-K · filed 2023-02-27 | $260.10M derived: sum of 2 quarters · filed 2023-02-27 | $388.50M derived: sum of 3 quarters · filed 2023-02-27 | $529.90M derived: sum of 4 quarters · filed 2023-02-27 |
| 2022-03-31 | $131.50M 10-K · filed 2023-02-27 | $259.90M derived: sum of 2 quarters · filed 2023-02-27 | $401.30M derived: sum of 3 quarters · filed 2023-02-27 | $548.10M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-12-31 | $128.40M 10-K · filed 2023-02-27 | $269.80M derived: sum of 2 quarters · filed 2023-02-27 | $416.60M derived: sum of 3 quarters · filed 2023-02-27 | $559.60M 10-K · filed 2023-02-27 |
| 2021-09-30 | $141.40M 10-K · filed 2023-02-27 | $288.20M derived: sum of 2 quarters · filed 2023-02-27 | $431.20M derived: sum of 3 quarters · filed 2023-02-27 | $599.50M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $146.80M 10-K · filed 2023-02-27 | $289.80M derived: sum of 2 quarters · filed 2023-02-27 | $458.10M derived: sum of 3 quarters · filed 2023-02-27 | $609.20M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $143.00M 10-K · filed 2023-02-27 | $311.30M derived: sum of 2 quarters · filed 2023-02-27 | $462.40M derived: sum of 3 quarters · filed 2023-02-27 | $547.60M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $168.30M 10-K · filed 2021-02-26 | $319.40M derived: sum of 2 quarters · filed 2021-02-26 | $404.60M derived: sum of 3 quarters · filed 2021-02-26 | $563.90M 10-K · filed 2021-02-26 |
| 2020-09-30 | $151.10M 10-K · filed 2021-02-26 | $236.30M derived: sum of 2 quarters · filed 2021-02-26 | $395.60M derived: sum of 3 quarters · filed 2021-02-26 | $536.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2020-06-30 | $85.20M 10-K · filed 2021-02-26 | $244.50M derived: sum of 2 quarters · filed 2021-02-26 | $385.70M derived: sum of 3 quarters · filed 2021-02-26 | $536.90M derived: sum of 4 quarters · filed 2021-02-26 |
| 2020-03-31 | $159.30M 10-K · filed 2021-02-26 | $300.50M derived: sum of 2 quarters · filed 2021-02-26 | $451.70M derived: sum of 3 quarters · filed 2021-02-26 | $604.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-12-31 | $141.20M 10-K · filed 2021-02-26 | $292.40M derived: sum of 2 quarters · filed 2021-02-26 | $445.00M derived: sum of 3 quarters · filed 2021-02-26 | $612.10M 10-K · filed 2021-02-26 |
| 2019-09-30 | $151.20M 10-K · filed 2021-02-26 | $303.80M derived: sum of 2 quarters · filed 2021-02-26 | $470.90M derived: sum of 3 quarters · filed 2021-02-26 | $564.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $152.60M 10-K · filed 2021-02-26 | $319.70M derived: sum of 2 quarters · filed 2021-02-26 | $413.10M derived: sum of 3 quarters · filed 2021-02-26 | $567.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $167.10M 10-K · filed 2021-02-26 | $260.50M derived: sum of 2 quarters · filed 2021-02-26 | $415.00M derived: sum of 3 quarters · filed 2021-02-26 | $572.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $93.40M 10-K · filed 2020-02-27 | $247.90M derived: sum of 2 quarters · filed 2020-02-27 | $405.20M derived: sum of 3 quarters · filed 2020-02-27 | $555.20M 10-K · filed 2020-02-27 |
| 2018-09-30 | $154.50M 10-K · filed 2020-02-27 | $311.80M derived: sum of 2 quarters · filed 2020-02-27 | $461.80M derived: sum of 3 quarters · filed 2020-02-27 | $606.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $157.30M 10-K · filed 2020-02-27 | $307.30M derived: sum of 2 quarters · filed 2020-02-27 | $452.00M derived: sum of 3 quarters · filed 2020-02-27 | $597.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $150.00M 10-K · filed 2020-02-27 | $294.70M derived: sum of 2 quarters · filed 2020-02-27 | $439.90M derived: sum of 3 quarters · filed 2020-02-27 | $581.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $144.70M 10-K · filed 2019-02-27 | $289.90M derived: sum of 2 quarters · filed 2019-02-27 | $431.20M derived: sum of 3 quarters · filed 2019-02-27 | $578.30M 10-K · filed 2019-02-27 |
| 2017-09-30 | $145.20M 10-K · filed 2019-02-27 | $286.50M derived: sum of 2 quarters · filed 2019-02-27 | $433.60M derived: sum of 3 quarters · filed 2019-02-27 | $579.10M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $141.30M 10-K · filed 2019-02-27 | $288.40M derived: sum of 2 quarters · filed 2019-02-27 | $433.90M derived: sum of 3 quarters · filed 2019-02-27 | $582.10M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $147.10M 10-K · filed 2019-02-27 | $292.60M derived: sum of 2 quarters · filed 2019-02-27 | $440.80M derived: sum of 3 quarters · filed 2019-02-27 | $591.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $145.50M 10-K · filed 2018-02-28 | $293.70M derived: sum of 2 quarters · filed 2018-02-28 | $443.90M derived: sum of 3 quarters · filed 2018-02-28 | $588.10M 10-K · filed 2018-02-28 |
| 2016-09-30 | $148.20M 10-K · filed 2018-02-28 | $298.40M derived: sum of 2 quarters · filed 2018-02-28 | $442.60M derived: sum of 3 quarters · filed 2018-02-28 | $578.10M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $150.20M 10-K · filed 2018-02-28 | $294.40M derived: sum of 2 quarters · filed 2018-02-28 | $429.90M derived: sum of 3 quarters · filed 2018-02-28 | $551.10M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $144.20M 10-K · filed 2018-02-28 | $279.70M derived: sum of 2 quarters · filed 2018-02-28 | $400.90M derived: sum of 3 quarters · filed 2018-02-28 | $524.30M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $135.50M 8-K · filed 2017-09-19 | $256.70M derived: sum of 2 quarters · filed 2017-09-19 | $380.10M derived: sum of 3 quarters · filed 2017-09-19 | $485.70M 8-K · filed 2017-09-19 |
| 2015-09-30 | $121.20M 8-K · filed 2017-09-19 | $244.60M derived: sum of 2 quarters · filed 2017-09-19 | $350.20M derived: sum of 3 quarters · filed 2017-09-19 | |
| 2015-06-30 | $123.40M 8-K · filed 2017-09-19 | $229.00M derived: sum of 2 quarters · filed 2017-09-19 | ||
| 2015-03-31 | $105.60M 8-K · filed 2017-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |